13:56 25/05/2017 Decision Time: Arena Pharmaceuticals Inc (NASDAQ:ARNA) Stock Technicals Hit ...
Decision Time: Arena Pharmaceuticals Inc (NASDAQ:ARNA) Stock Technicals Hit ...
CML News - 5 hours ago
Decision Time: Arena Pharmaceuticals Inc (NASDAQ:ARNA) now sits in the perhaps the most difficult technical position -- the stock has no urgency in its direction and that has left it at an inflection point.

11:52 25/05/2017 Arena Pharmaceuticals, Inc. (ARNA) Now Covered by Analysts at Leerink Swann
Arena Pharmaceuticals, Inc. (ARNA) Now Covered by Analysts at Leerink Swann
BNB Daily (blog) - 7 hours ago
Arena Pharmaceuticals, Inc. logo Leerink Swann assumed coverage on shares of Arena Pharmaceuticals, Inc. (NASDAQ:ARNA) in a research report report published on Friday morning. The brokerage issued an outperform rating and a $5.00 price objective ...
Arena Pharmaceuticals, Inc. (ARNA) currently has an analysts' mean ... - StandardOracle

13:45 23/05/2017 Traders Secrets on Arena Pharmaceuticals, Inc. (ARNA), Analog Devices, Inc. (ADI)
Traders Secrets on Arena Pharmaceuticals, Inc. (ARNA), Analog Devices, Inc. (ADI)
StockNewsJournal - May 23, 2017
ROI deals with the invested cash in the company and the return the investor realize on that money based on the net profit of the business.

20:07 22/05/2017 Arena Pharmaceuticals, Inc. (ARNA): An Examination Of The Chart For Today's ...
Arena Pharmaceuticals, Inc. (ARNA): An Examination Of The Chart For Today's ...
NY Stock News - May 22, 2017
Arena Pharmaceuticals, Inc. (ARNA) has presented a rich pool of technical data in recent sessions. These are the trends we've been tracking and how we feel they should be played in the current environment.

19:56 19/05/2017 Arena Pharma Could Be Developing Several Best-In-Class Agents
Arena Pharma Could Be Developing Several Best-In-Class Agents
Benzinga - May 19, 2017
Management has "greatly improved its exposure to the company's legacy Belviq franchise by renegotiating its agreement with Eisai.
Taking a Fresh Look at Arena Pharmaceuticals, Inc. (ARNA) - StockNewsJournal
Arena Pharmaceuticals, Inc. (ARNA) Delivers Clear Picture With Technicals - NY Stock News

14:11 19/05/2017 Arena Pharmaceuticals Inc: Leerink starts with "outperform"
Arena Pharmaceuticals Inc: Leerink starts with "outperform"
Times of India - May 19, 2017
The new ARNA seeks to pursue markets it can commercialize on its own, although proof-of-concept (PoC) data in the company's lead programs which include could lead to interest from large pharmaceutical/biotechnology companies, the analysts added.

21:33 16/05/2017 Arena Pharmaceuticals to Present Phase 1 Data on Ralinepag for Treatment of ...
Arena Pharmaceuticals to Present Phase 1 Data on Ralinepag for Treatment of ...
PR Newswire (press release) - May 16, 2017
SAN DIEGO, May 16, 2017 /PRNewswire/ -- Arena Pharmaceuticals, Inc. (NASDAQ: ARNA) will present detailed Phase 1 data on ralinepag (APD811), the Company's next-generation, oral, selective prostacyclin receptor (IP) agonist intended for the treatment ...

13:56 15/05/2017 Why Traders Are Paying Attention To The Chart of Arena Pharmaceuticals, Inc ...
Why Traders Are Paying Attention To The Chart of Arena Pharmaceuticals, Inc ...
NY Stock News - May 15, 2017
Arena Pharmaceuticals, Inc. (ARNA) has been having a set of eventful trading activity and it is clear from an examination of the charts that traders are now fully aware of the company's key metrics.

16:14 04/05/2017 Arena Pharmaceuticals (ARNA) Q1 Earnings: What's in Store?
Arena Pharmaceuticals (ARNA) Q1 Earnings: What's in Store?
Yahoo Finance - May 4, 2017
Arena Pharmaceuticals, Inc. ARNA is expected to report first-quarter 2017 on May 9, after market closes. The company delivered a positive earnings surprise of 277.78% in the last quarter.
Arena Pharmaceuticals (ARNA) Posts Q1 Loss, Revenues Down - Zacks.com
Arena Pharmaceuticals Provides Corporate Update and Reports First Quarter 2017 ... - PR Newswire (press release)

3:48 29/04/2017 Arena Pharmaceuticals Inc (NASDAQ:ARNA) is Attracting Smart Money
Arena Pharmaceuticals Inc (NASDAQ:ARNA) is Attracting Smart Money
Small Cap Exclusive (press release) - Apr 29, 2017
In a just published Form 13, filed with the US Securities and Exchange Commission (SEC), Arena Pharmaceuticals Inc (NASDAQ:ARNA) reported that Great Point Partners has picked up 30,000,000 of common stock as of 2017-04-28.
Today's Brokerage Rating: Arena Pharmaceuticals, Inc. (ARNA), Coty Inc. (COTY) - StockNewsJournal
Analytical Guide for Arena Pharmaceuticals, Inc. (ARNA), SiteOne Landscape ... - The USA Commerce